Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Publication year range
1.
Am J Chin Med ; 43(2): 231-40, 2015.
Article in English | MEDLINE | ID: mdl-25800905

ABSTRACT

The effects of neferine, a bisbenzylisoquinline alkaloid extracted from the seed embryo of the Chinese traditional medicine Nelumbo nucifera Gaertn, on carbon tetrachloride (CCl4)-induced hepatic fibrosis in mice were evaluated. Adult male Kunming mice were administered with CCl4 1 ml/kg via intraperitoneal injection twice a week for 8 weeks. At the beginning of the 9th week, mice were treated with normal saline, colchicine (0.1 mg/kg), and neferine (5, 10, 20 mg/kg) via intraperitoneal injection once a day for 2 weeks. The liver index and histological examination, plasma ALT/AST levels, hydroxyproline and TGF-ß1 content of liver tissue were examined. In the model group, the liver index, the hydroxyproline content of liver tissue and plasma ALT/AST levels were increased, and a high expression of TGF-ß1 was observed. The abnormal changes could be improved by neferine in a dose-dependent manner. Our data showed that neferine had an antifibrosis effect on CCl4-induced hepatic fibrosis in mice, possibly partly due to the decreased expression of TGF-ß1 in the liver.


Subject(s)
Benzylisoquinolines/therapeutic use , Carbon Tetrachloride , Liver Cirrhosis/chemically induced , Liver Cirrhosis/drug therapy , Phytotherapy , Animals , Benzylisoquinolines/administration & dosage , Benzylisoquinolines/isolation & purification , Benzylisoquinolines/pharmacology , Dose-Response Relationship, Drug , Injections, Intraperitoneal , Liver/metabolism , Liver Cirrhosis/metabolism , Male , Mice, Inbred Strains , Nelumbo/chemistry , Transforming Growth Factor beta1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL